Search

You searched for "pathology"

1342 results found

Rayner announces acquisition of Sophi

17 January 2024 | Contracts & Distributors, Company Profiles
Rayner, a global leader in products for cataract surgery headquartered in Worthing, UK, announced today (17 January 2024) that it has entered into a definitive agreement to acquire Swiss-based This AG, the inventor, developer and manufacturer of Sophi phaco emulsification machines.

Oertli Instrumente AG wins the Swiss Medtech Award

12 June 2024 | Awards, Conferences & Anniversaries, Company Profiles
Oertli Instrumente AG has been honored with the prestigious Swiss Medtech Award, worth CHF 75,000 at the Swiss Medtech Day.

Glaukos Launches iStent infinite® in the UK Following MDR Approval

2 October 2025 | Company Profiles, Research & Development
Glaukos has announced the launch of its latest glaucoma treatment, iStent infinite®, in the UK market after securing approval under the European Medical Device Regulation (MDR). This new approval process is rigorous and provides ophthalmologists with reassurance regarding the efficacy...

In conversation with Charles Leclercq (ARxVision)

5 October 2022 | | EYE - General
Julian Jackson (Founder and Director, VisionBridge) spoke to Charles Leclercq (CEO, ARx) about the ARxVision, a wearable device that captures the world around us through audio and artificial intelligence to empower blind and low-vision individuals. You can read the Eye...

Visual disturbance heralding stroke: are we seeing the signs in time?

6 April 2021 | | EYE - Neuro-ophthalmology, EYE - General
Isolated visual symptoms may be an early presenting feature of stroke, and timely recognition of such atypical cases is important because treatment for stroke has a limited time-window of efficacy. Stroke occurs in approximately 150,000 people per year in the...

The management of antiplatelets and anticoagulation in elective ophthalmic surgery

1 April 2016 | | EYE - Orbit, EYE - Oculoplastic
Clinical scenario: A 57-year-old gentleman who is scheduled to have Mohs micrographic surgery and reconstruction for a medial canthal basel cell carcinoma (BCC) has been started on aspirin and clopidogrel following a coronary stent three weeks ago. Does the antiplatelet...

Broadening of treatment options for potentially blinding retinal conditions

2 August 2022 | | EYE - General
Rod McNeil provides an update on a promising bispecific antibody recently approved for treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO) and considers emerging developments in biosimilars to established anti-vascular endothelial growth factor (anti-VEGF) therapies, including...

New funding will support development of wearable diagnostics for neuromuscular diseases

1 November 2023 | Hadi Heidari, Glasgow University, Neuromuscular, funding, awards, new technology
A researcher from the University of Glasgow has received an EPSRC Open Fellowship to develop new wearable technology capable of measuring the progress of neuromuscular diseases.

Orbis and Heidelberg Engineering team up on free e-learning opportunities

12 April 2024 | Orbis, charity, international, collaboration, partnership, educational, learning, work
Sight-saving charity Orbis and high-tech imaging and data solutions company Heidelberg Engineering are leveraging technology to provide free clinical education for eye care professionals around the world.

Pioneering accessible technology conference returns to Glasgow in 2025

29 January 2025 | meetings, events, technology, Scotland, accessibility
RNIB Scotland’s Inclusive Design for Sustainability (IDS) Conference is set to return to Glasgow Science Centre on 17 and 18 March 2025, bringing together global tech giants and accessibility advocates to explore the future of inclusive design. The event, which...

Optegra Eye Health Care & ZEISS Symposium - Hands-on with latest innovations in ophthalmology

4 July 2024
This interactive symposium, presented by Optegra Eye Care and ZEISS, will explore the latest advancements in surgical techniques, diagnostic tools, and patient care. We are proud to announce a special emphasis on practical learning through hands-on workshops

ZEISS CPD Webinar: OCT Essentials for Diabetes

18 September 2024
Speaker: Adam Heritage (ZEISS Clinical Applications Specialist) As OCT becomes increasingly important in the early detection and management of diabetic eye diseases, understanding the principles and applications of OCT is crucial. That’s why ZEISS are proud to present an interactive...